Risk assessment for the amino acids taurine, l-glutamine and l-arginine

Regulatory Toxicology and Pharmacology

Volumn 50, Issue 3, 2008, Pages 376-399

  Shao, Andrew ^a   Hathcock, John N ^a  

^a International and Scientific Affairs   (United States)

Author keywords

Amino acids; l Arginine; l Glutamine; Observed Safe Level (OSL); Taurine; Upper level of intake (UL)

Indexed keywords

AMINO ACID; ARGININE; GLUTAMINE; TAURINE;

ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ANIMALS; ARGININE; BEVERAGES; CHILD; DATA INTERPRETATION, STATISTICAL; DIETARY SUPPLEMENTS; FOOD ANALYSIS; GLUTAMINE; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; TAURINE;

ANIMALIA;

EID: 41949114267     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.01.004     Document Type: Article

References (198)

1. Abdelhamed A.I., Reis S.E., Sane D.C., Brosnihan K.B., Preli R.B., and Herrington D.M. No effect of an l-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia. Am. Heart J. 145 (2003) E15
2. Abumrad N.N., and Barbul A. Arginine therapy for acute myocardial infarction. JAMA 295 (2006) 2138-2139 author reply 2139-2140
3. Adams M.R., Forsyth C.J., Jessup W., Robinson J., and Celermajer D.S. Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J. Am. Coll. Cardiol. 26 (1995) 1054-1061
4. Alexander J.W., Metze T.J., McIntosh M.J., Goodman H.R., First M.R., Munda R., Cardi M.A., Austin J.N., Goel S., Safdar S., Greenberg N., Chen X., and Woodle E.S. The influence of immunomodulatory diets on transplant success and complications. Transplantation 79 (2005) 460-465
5. Alford C., Cox H., and Wescott R. The effects of red bull energy drink on human performance and mood. Amino Acids 21 (2001) 139-150
6. Alpers D.H. Glutamine: do the data support the cause for glutamine supplementation in humans?. Gastroenterology 130 (2006) S106-S116
7. Antonio J., and Street C. Glutamine: a potentially useful supplement for athletes. Can J. Appl. Physiol. 24 (1999) 1-14
8. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern. Med. Rev. 7 (2002) 512-522
9. Arwert L.I., Deijen J.B., and Drent M.L. Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects. Nutr. Neurosci. 6 (2003) 269-275
10. Avenell A. Glutamine in critical care: current evidence from systematic reviews. Proc. Nutr. Soc. 65 (2006) 236-241
11. Azuma J., Hasegawa H., Sawamura A., Awata N., Harada H., Ogura K., and Kishimoto S. Taurine for treatment of congestive heart failure. Int. J. Cardiol. 2 (1982) 303-304
12. Azuma J., Hasegawa H., Sawamura A., Awata N., Ogura K., Harada H., Yamamura Y., and Kishimoto S. Therapy of congestive heart failure with orally administered taurine. Clin. Ther. 5 (1983) 398-408
13. Azuma J., Sawamura A., Awata N., Ohta H., Hamaguchi T., Harada H., Takihara K., Hasegawa H., Yamagami T., Ishiyama T., et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin. Cardiol. 8 (1985) 276-282
14. Azuma J., Sawamura A., and Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn. Circ. J. 56 (1992) 95-99
15. Baker D.H. Comparative species utilization and toxicity of sulfur amino acids. J. Nutr. 136 (2006) 1670S-1675S
16. Balch M.D., James A., Balch C.N.C., and Phyllis A. Prescription for Nutritional Healing (1997), Avery Publishing Group, Garden City Park, NY
17. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. JPEN J. Parenter. Enteral. Nutr. 10 (1986) 227-238
18. Barbul A., Sisto D.A., Wasserkrug H.L., and Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 90 (1981) 244-251
19. Barbul A., Lazarou S.A., Efron D.T., Wasserkrug H.L., and Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 108 (1990) 331-336 discussion 336-337
20. Barthel T., Mechau D., Wehr T., Schnittker R., Liesen H., and Weiss M. Readiness potential in different states of physical activation and after ingestion of taurine and/or caffeine containing drinks. Amino Acids 20 (2001) 63-73
21. Battaglia C., Regnani G., Marsella T., Facchinetti F., Volpe A., Venturoli S., and Flamigni C. Adjuvant l-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum. Reprod. 17 (2002) 659-665
22. Bednarz B., Jaxa-Chamiec T., Gebalska J., Herbaczynska-Cedro K., and Ceremuzynski L. l-Arginine supplementation prolongs exercise capacity in congestive heart failure. Kardiol. Pol. 60 (2004) 348-353
23. Bednarz B., Jaxa-Chamiec T., Maciejewski P., Szpajer M., Janik K., Gniot J., Kawka-Urbanek T., Drozdowska D., Gessek J., and Laskowski H. Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Kardiol. Pol. 62 (2005) 421-427
24. Belli D.C., Levy E., Darling P., Leroy C., Lepage G., Giguere R., and Roy C.C. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Pediatrics 80 (1987) 517-523
25. Bennett-Richards K.J., Kattenhorn M., Donald A.E., Oakley G.R., Varghese Z., Bruckdorfer K.R., Deanfield J.E., and Rees L. Oral l-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 62 (2002) 1372-1378
26. Bichler A., Swenson A., and Harris M.A. A combination of caffeine and taurine has no effect on short term memory but induces changes in heart rate and mean arterial blood pressure. Amino Acids 31 (2006) 471-476
27. Bode-Boger S.M., Muke J., Surdacki A., Brabant G., Boger R.H., and Frolich J.C. Oral l-Arginine improves endothelial function in healthy individuals older than 70 years. Vasc. Med. 8 (2003) 77-81
28. Braga M., Gianotti L., Vignali A., and Carlo V.D. Preoperative oral Arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132 (2002) 805-814
29. Brons C., Spohr C., Storgaard H., Dyerberg J., and Vaag A. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur. J. Clin. Nutr. 58 (2004) 1239-1247
30. Brosnan J.T., and Brosnan M.E. The sulfur-containing amino acids: an overview. J. Nutr. 136 (2006) 1636S-1640S
31. Buchman A.L. Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data. Am. J. Clin. Nutr. 74 (2001) 25-32
32. Buchman A.L., O'Brien W., Ou C.N., Rognerud C., Alvarez M., Dennis K., and Ahn C. The effect of arginine or glycine supplementation on gastrointestinal function, muscle injury, serum amino acid concentrations and performance during a marathon run. Int. J. Sports Med. 20 (1999) 315-321
33. Candow D.G., Chilibeck P.D., Burke D.G., Davison K.S., and Smith-Palmer T. Effect of glutamine supplementation combined with resistance training in young adults. Eur. J. Appl. Physiol. 86 (2001) 142-149
34. Cangemi F.E. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol. 7 (2007) 3
35. Chauncey K.B., Tenner Jr. T.E., Lombardini J.B., Jones B.G., Brooks M.L., Warner R.D., Davis R.L., and Ragain R.M. The effect of taurine supplementation on patients with type 2 diabetes mellitus. Adv. Exp. Med. Biol. 526 (2003) 91-96
36. Chesney R.W., Gusowski N., and Dabbagh S. Renal cortex taurine content regulates renal adaptive response to altered dietary intake of sulfur amino acids. J. Clin. Invest. 76 (1985) 2213-2221
37. Chin-Dusting J.P., Alexander C.T., Arnold P.J., Hodgson W.C., Lux A.S., and Jennings G.L. Effects of in vivo and in vitro l-arginine supplementation on healthy human vessels. J. Cardiovasc. Pharmacol. 28 (1996) 158-166
38. Chin-Dusting J.P., Kaye D.M., Lefkovits J., Wong J., Bergin P., and Jennings G.L. Dietary supplementation with l-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J. Am. Coll. Cardiol. 27 (1996) 1207-1213
39. Clark R.H., Feleke G., Din M., Yasmin T., Singh G., Khan F.A., and Rathmacher J.A. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and Arg: a randomized, double-blind, placebo-controlled study. JPEN J. Parenter. Enteral. Nutr. 24 (2000) 133-139
40. Clarkson P., Adams M.R., Powe A.J., Donald A.E., McCredie R., Robinson J., McCarthy S.N., Keech A., Celermajer D.S., and Deanfield J.E. Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J. Clin. Invest. 97 (1996) 1989-1994
41. Colgan M. Optimum Sports Nutrition: Your Competitive Edge (1993), Advanced Research Press, Ronkonkoma, NY
42. Colombani P.C., Bitzi R., Frey-Rindova P., Frey W., Arnold M., Langhans W., and Wenk C. Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run. Eur. J. Nutr. 38 (1999) 263-270
43. Colombo C., Arlati S., Curcio L., Maiavacca R., Garatti M., Ronchi M., Corbetta C., and Giunta A. Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis. Scand. J. Gastroenterol. Suppl. 143 (1988) 151-156
44. Colombo C., Battezzati P.M., Podda M., Bettinardi N., and Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian group for the study of ursodeoxycholic acid in cystic fibrosis. Hepatology 23 (1996) 1484-1490
45. Cooke R.J., Whitington P.F., and Kelts D. Effect of taurine supplementation on hepatic function during short-term parenteral nutrition in the premature infant. J. Pediatr. Gastroenterol. Nutr. 3 (1984) 234-238
46. Daly J.M., Reynolds J., Thom A., Kinsley L., Dietrick-Gallagher M., Shou J., and Ruggieri B. Immune and metabolic effects of arginine in the surgical patient. Ann. Surg. 208 (1988) 512-523
47. Darling P.B., Lepage G., Leroy C., Masson P., and Roy C.C. Effect of taurine supplements on fat absorption in cystic fibrosis. Pediatr. Res. 19 (1985) 578-582
48. De Nicola L., Bellizzi V., Minutolo R., Andreucci M., Capuano A., Garibotto G., Corso G., Andreucci V.E., and Cianciaruso B. Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. Kidney Int. 56 (1999) 674-684
49. De-Souza D.A., and Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit. Care Med. 33 (2005) 1125-1135
50. Domke A., Grossklaus R., Niemann B., Przyrembel H., Richter K., Schmide E., Weissenborn A., Wörner B., and Ziegenhagen R. Use of Vitamins in Foods (2006), Federal Institute for Risk Assessment (Germany), Berlin, Germany
51. Doutreleau S., Mettauer B., Piquard F., Rouyer O., Schaefer A., Lonsdorfer J., and Geny B. Chronic l-arginine supplementation enhances endurance exercise tolerance in heart failure patients. Int. J. Sports Med. 27 (2006) 567-572
52. Dudek D., Legutko J., Heba G., Bartus S., Partyka L., Huk I., Dembinska-Kiec A., Kaluza G.L., and Dubiel J.S. l-Arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study. Am. Heart J. 147 (2004) E12
53. Durelli L., Mutani R., and Fassio F. The treatment of myotonia: evaluation of chronic oral taurine therapy. Neurology 33 (1983) 599-603
54. European Commission. Scientific Committee on Food, 2001. Guidelines of the Scientific Committee on Food for the Development of Tolerable Upper Intake Levels for Vitamins and Minerals, Brussels, Belgium.
55. Evans R.W., Fernstrom J.D., Thompson J., Morris Jr. S.M., and Kuller L.H. Biochemical responses of healthy subjects during dietary supplementation with l-arginine. J. Nutr. Biochem. 15 (2004) 534-539
56. Falk D.J., Heelan K.A., Thyfault J.P., and Koch A.J. Effects of effervescent creatine, ribose, and glutamine supplementation on muscular strength, muscular endurance, and body composition. J. Strength Cond. Res. 17 (2003) 810-816
57. Food and Agriculture Organization/World Health Organization (FAO/WHO). A Model for Establishing Upper Levels of Intake for Nutrients and Related Substances, 2006. Technical Workshop on Nutrient Risk Assessment, Geneva, Switzerland. .
58. Ferreira S.E., de Mello M.T., Rossi M.V., and Souza-Formigoni M.L. Does an energy drink modify the effects of alcohol in a maximal effort test?. Alcohol Clin. Exp. Res. 28 (2004) 1408-1412
59. Ferreira S.E., Hartmann Quadros I.M., Trindade A.A., Takahashi S., Koyama R.G., and Souza-Formigoni M.L. Can energy drinks reduce the depressor effect of ethanol? An experimental study in mice. Physiol. Behav. 82 (2004) 841-847
60. Ferreira S.E., de Mello M.T., Pompeia S., and de Souza-Formigoni M.L. Effects of energy drink ingestion on alcohol intoxication. Alcohol Clin. Exp. Res. 30 (2006) 598-605
61. Food Standards Agency. Expert Group on Vitamins and Minerals, 2003. Safe Upper Levels for Vitamins and Minerals. United Kingdom.
62. Franconi F., Bennardini F., Mattana A., Miceli M., Ciuti M., Mian M., Gironi A., Anichini R., and Seghieri G. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am. J. Clin. Nutr. 61 (1995) 1115-1119
63. Franconi F., Loizzo A., Ghirlanda G., and Seghieri G. Taurine supplementation and diabetes mellitus. Curr. Opin. Clin. Nutr. Metab. Care 9 (2006) 32-36
64. Fujita T., Ando K., Noda H., Ito Y., and Sato Y. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75 (1987) 525-532
65. Galeano N.F., Darling P., Lepage G., Leroy C., Collet S., Giguere R., and Roy C.C. Taurine supplementation of a premature formula improves fat absorption in preterm infants. Pediatr. Res. 22 (1987) 67-71
66. Garlick P.J. Assessment of the safety of glutamine and other amino acids. J. Nutr. 131 (2001) 2556S-2561S
67. Garlick P.J. The nature of human hazards associated with excessive intake of amino acids. J. Nutr. 134 (2004) 1633S-1639S discussion 1664S-1666S, 1667S-1672S
68. Garlick P.J. Toxicity of methionine in humans. J Nutr. 136 (2006) 1722S-1725S
69. Gerard J.M., and Luisiri A. A fatal overdose of arginine hydrochloride. J. Toxicol. Clin. Toxicol. 35 (1997) 621-625
70. Gleeson M., Nieman D.C., and Pedersen B.K. Exercise, nutrition and immune function. J. Sports Sci. 22 (2004) 115-125
71. Grasemann H., Grasemann C., Kurtz F., Tietze-Schillings G., Vester U., and Ratjen F. Oral l-arginine supplementation in cystic fibrosis patients: a placebo-controlled study. Eur. Respir. J. 25 (2005) 62-68
72. Gray G.E., Landel A.M., and Meguid M.M. Taurine-supplemented total parenteral nutrition and taurine status of malnourished cancer patients. Nutrition 10 (1994) 11-15
73. Grimble R.F. The effects of sulfur amino acid intake on immune function in humans. J. Nutr. 136 (2006) 1660S-1665S
74. Grimble G.K. Adverse gastrointestinal effects of arginine and related amino acids. J. Nutr. 137 (2007) 1693S-1701S
75. Hambrecht R., Hilbrich L., Erbs S., Gielen S., Fiehn E., Schoene N., and Schuler G. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral l-arginine supplementation. J. Am. Coll. Cardiol. 35 (2000) 706-713
76. Harding G.F., Grose J., Wilton A.Y., and Bissenden J.G. The pattern reversal VEP in short-gestation infants on taurine or taurine-free diet. Doc. Ophthalmol. 73 (1989) 103-109
77. Hathcock J. Vitamin and Mineral Safety (2004), Council for Responsible Nutrition, Washington, DC
78. Hathcock J.N., and Shao A. Risk assessment for carnitine. Regul. Toxicol. Pharmacol. 46 (2006) 23-28
79. Hathcock J.N., and Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul. Toxicol. Pharmacol. 45 (2006) 282-288
80. Hathcock J.N., and Shao A. Risk assessment for glucosamine and chondroitin sulfate. Regul. Toxicol. Pharmacol. 47 (2007) 78-83
81. Hathcock J.N., Shao A., Vieth R., and Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 85 (2007) 6-18
82. Hayashi Y. Application of the concepts of risk assessment to the study of amino acid supplements. J. Nutr. 133 (2003) 2021S-2024S
83. Hayes K.C. Taurine requirement in primates. Nutr. Rev. 43 (1985) 65-70
84. Hayes K.C., and Trautwein E.A. Taurine deficiency syndrome in cats. Vet. Clin. North Am. Small Anim. Pract. 19 (1989) 403-413
85. Hayes K.C., and Trautwein E.A. Taurine. Modern Nutrition in Health and Disease (1994), Lea and Febiger (pp. 477-485)
86. Health Canada, Canadian Adverse Drug Reaction Monitoring Program (CADRMP). Health Canada advises heart patients not to use products containing l-arginine. May 2006. Ottowa, ON, Canada. .
87. Hurson M., Regan M.C., Kirk S.J., Wasserkrug H.L., and Barbul A. Metabolic effects of arginine in a healthy elderly population. JPEN J. Parent. Enter. Nutr. 19 (1995) 227-230
88. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72 (1992) 101-163
89. Huxtable R.J. Taurine. Past, present, and future. Adv. Exp. Med. Biol. 403 (1996) 641-650
90. Institute of Medicine. Food and Nutrition Board, 1997. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, Washington, DC.
91. Institute of Medicine. Food and Nutrition Board, 1998a. Dietary Reference Intakes: A Risk Assessment Model for Establishing Upper Intake Levels for Nutrients. National Academy Press, Washington, DC.
92. Institute of Medicine. Food and Nutrition Board, 1998b. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. National Academy Press, Washington, DC.
93. Institute of Medicine. Food and Nutrition Board, 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. National Academy Press, Washington, DC.
94. Institute of Medicine. Food and Nutrition Board, 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. National Academy Press, Washington, DC.
95. Ishizaka S., Kuriyama S., Kikuchi E., Nishimura K., and Tsujii T. A novel oral adjuvant for hepatitis B virus (HBV) vaccines. J. Hepatol. 11 (1990) 326-329
96. Jarvenpaa A.L., Raiha N.C., Rassin D.K., and Gaull G.E. Feeding the low-birth-weight infant: I. Taurine and cholesterol supplementation of formula does not affect growth and metabolism. Pediatrics 71 (1983) 171-178
97. Jeejeebhoy F., Keith M., Freeman M., Barr A., McCall M., Kurian R., Mazer D., and Errett L. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am. Heart J. 143 (2002) 1092-1100
98. Kelly B.S., Alexander J.W., Dreyer D., Greenberg N.A., Erickson A., Whiting J.F., Ogle C.K., Babcock G.F., and First M.R. Oral arginine improves blood pressure in renal transplant and hemodialysis patients. JPEN J. Parenter. Enteral. Nutr. 25 (2001) 194-202
99. Kendler B.S. Taurine: an overview of its role in preventive medicine. Prev. Med. 18 (1989) 79-100
100. Kerksick C.M., Rasmussen C.J., Lancaster S.L., Magu B., Smith P., Melton C., Greenwood M., Almada A.L., Earnest C.P., and Kreider R.B. The effects of protein and amino acid supplementation on performance and training adaptations during ten weeks of resistance training. J. Strength Cond. Res. 20 (2006) 643-653
101. Khan F., and Belch J.J. Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral l-arginine supplementation. J Rheumatol. 26 (1999) 2389-2394
102. Khan F., Litchfield S.J., McLaren M., Veale D.J., Littleford R.C., and Belch J.J. Oral l-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum. 40 (1997) 352-357
103. Kirk S.J., Hurson M., Regan M.C., Holt D.R., Wasserkrug H.L., and Barbul A. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 114 (1993) 155-159 discussion 160
104. Kreider R.B. Dietary supplements and the promotion of muscle growth with resistance exercise. Sports Med. 27 (1999) 97-110
105. Kreider R.B., Ferreira M., Wilson M., Grindstaff P., Plisk S., Reinardy J., Cantler E., and Almada A.L. Effects of creatine supplementation on body composition, strength, and sprint performance. Med. Sci. Sports Exerc. 30 (1998) 73-82
106. Krieger J.W., Crowe M., and Blank S.E. Chronic glutamine supplementation increases nasal but not salivary IgA during 9 days of interval training. J. Appl. Physiol. 97 (2004) 585-591
107. Kuhn K.S., Stehle P., and Furst P. Glutamine content of protein and peptide-based enteral products. JPEN J. Parenter. Enteral. Nutr. 20 (1996) 292-295
108. Lacey J.M., and Wilmore D.W. Is glutamine a conditionally essential amino acid?. Nutr. Rev. 48 (1990) 297-309
109. Laidlaw S.A., Shultz T.D., Cecchino J.T., and Kopple J.D. Plasma and urine taurine levels in vegans. Am. J. Clin. Nutr. 47 (1988) 660-663
110. Laidlaw S.A., Grosvenor M., and Kopple J.D. The taurine content of common foodstuffs. JPEN J. Parenter. Enteral. Nutr. 14 (1990) 183-188
111. Langkamp-Henken B., Herrlinger-Garcia K.A., Stechmiller J.K., Nickerson-Troy J.A., Lewis B., and Moffatt L. Arginine supplementation is well tolerated but does not enhance mitogen-induced lymphocyte proliferation in elderly nursing home residents with pressure ulcers. JPEN J. Parenter. Enteral. Nutr. 24 (2000) 280-287
112. l-Arginine, 2005. Kyowa Hakko Kogyo Co., Ltd., Bio-Chemicals Business Unit, Tokyo, Japan.
113. Lehmkuhl M., Malone M., Justice B., Trone G., Pistilli E., Vinci D., Haff E.E., Kilgore J.L., and Haff G.G. The effects of 8 weeks of creatine monohydrate and glutamine supplementation on body composition and performance measures. J. Strength Cond. Res. 17 (2003) 425-438
114. Le ministre de l'économie, des finances et de l'industrie, 2006. Décrets, arêtés, circulaires-textes généraux. Arrêté de 9 mai 2006 relatif aux nutriments pouvant être employés dan la fabrication de compléments alimentarires. Journal Officiel de la Républic Française. Texte 7 sur 62.
115. Lerman A., Burnett Jr. J.C., Higano S.T., McKinley L.J., and Holmes Jr. D.R. Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97 (1998) 2123-2128
116. l-Glutamine, 2005. Kyowa Hakko Kogyo Co., Ltd., Bio-Chemicals Business Unit, Tokyo, Japan.
117. Lind D.S. Arginine and cancer. J. Nutr. 134 (2004) 2837S-2841S discussion 2853S
118. Lowe D.K., Benfell K., Smith R.J., Jacobs D.O., Murawski B., Ziegler T.R., and Wilmore D.W. Safety of glutamine-enriched parenteral nutrient solutions in humans. Am. J. Clin. Nutr. 52 (1990) 1101-1106
119. Lucotti P., Setola E., Monti L.D., Galluccio E., Costa S., Sandoli E.P., Fermo I., Rabaiotti G., Gatti R., and Piatti P. Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E906-E912
120. Marcora S., Lemmey A., and Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin. Nutr. 24 (2005) 442-454
121. Massara F., Cagliero E., Bisbocci D., Passarino G., Carta Q., and Molinatti G.M. The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject. Diabetes Metab. 7 (1981) 149-153
122. Maxwell A.J., Anderson B., Zapien M.P., and Cooke J.P. Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity. Cardiovasc. Drugs Ther. 14 (2000) 309-316
123. Maxwell A.J., Anderson B.E., and Cooke J.P. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc. Med. 5 (2000) 11-19
124. Maxwell A.J., Zapien M.P., Pearce G.L., MacCallum G., and Stone P.H. Randomized trial of a medical food for the dietary management of chronic, stable angina. J. Am. Coll. Cardiol. 39 (2002) 37-45
125. May P.E., Barber A., D'Olimpio J.T., Hourihane A., and Abumrad N.N. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, Arg, and glutamine. Am. J. Surg. 183 (2002) 471-479
126. Melis G.C., ter Wengel N., Boelens P.G., and van Leeuwen P.A. Glutamine: recent developments in research on the clinical significance of glutamine. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 59-70
127. Merli M., Bertasi S., Servi R., Diamanti S., Martino F., De Santis A., Goffredo F., Quattrucci S., Antonelli M., and Angelico M. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial. J. Pediatr. Gastroenterol. Nutr. 19 (1994) 198-203
128. Michalk D.V., Ringeisen R., Tittor F., Lauffer H., Deeg K.H., and Bohles H.J. Development of the nervous and cardiovascular systems in low-birth-weight infants fed a taurine-supplemented formula. Eur. J. Pediatr. 147 (1988) 296-299
129. Militante J.D., and Lombardini J.B. Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23 (2002) 381-393
130. Militante J., and Lombardini J.B. Age-related retinal degeneration in animal models of aging: possible involvement of taurine deficiency and oxidative stress. Neurochem. Res. 29 (2004) 151-160
131. Mizushima S., Nara Y., Sawamura M., and Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv. Exp. Med. Biol. 403 (1996) 615-622
132. Moriguti J.C., Ferriolli E., Donadi E.A., and Marchini J.S. Effects of arginine supplementation on the humoral and innate immune response of older people. Eur. J. Clin. Nutr. 59 (2005) 1362-1366
133. Nagaya N., Uematsu M., Oya H., Sato N., Sakamaki F., Kyotani S., Ueno K., Nakanishi N., Yamagishi M., and Miyatake K. Short-term oral administration of l-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 163 (2001) 887-891
134. National Research Council. Risk Assessment in the Federal Government: Managing the Process, 1983. National Academy Press, Washington, DC.
135. Noble D.W., and Avenell A. Glutamine-containing parenteral nutrition: another piece in the jigsaw?. Crit. Care. Med. 34 (2006) 893-894
136. Obinata K., Maruyama T., Hayashi M., Watanabe T., and Nittono H. Effect of taurine on the fatty liver of children with simple obesity. Adv. Exp. Med. Biol. 403 (1996) 607-613
137. Oka R.K., Szuba A., Giacomini J.C., and Cooke J.P. A pilot study of l-arginine supplementation on functional capacity in peripheral arterial disease. Vasc. Med. 10 (2005) 265-274
138. Paauw J.D., and Davis A.T. Taurine supplementation at three different dosages and its effect on trauma patients. Am. J. Clin. Nutr. 60 (1994) 203-206
139. Paddon-Jones D., Borsheim E., and Wolfe R.R. Potential ergogenic effects of arginine and creatine supplementation. J. Nutr. 134 (2004) 2888S-2894S discussion 2895S
140. Palloshi A., Fragasso G., Piatti P., Monti L.D., Setola E., Valsecchi G., Galluccio E., Chierchia S.L., and Margonato A. Effect of oral l-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am. J. Cardiol. 93 (2004) 933-935
141. Park K.G., Heys S.D., Blessing K., Kelly P., McNurlan M.A., Eremin O., and Garlick P.J. Stimulation of human breast cancers by dietary l-arginine. Clin. Sci. (Lond.) 82 (1992) 413-417
142. Petros A., Bennett D., and Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338 (1991) 1557-1558
143. Pichard C., Sudre P., Karsegard V., Yerly S., Slosman D.O., Delley V., Perrin L., and Hirschel B. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study. Aids 12 (1998) 53-63
144. Raiha N.C., Fazzolari-Nesci A., and Boehm G. Taurine supplementation prevents hyperaminoacidemia in growing term infants fed high-protein cow's milk formula. Acta Paediatr. 85 (1996) 1403-1407
145. Rana S.K., and Sanders T.A. Taurine concentrations in the diet, plasma, urine and breast milk of vegans compared with omnivores. Br. J. Nutr. 56 (1986) 17-27
146. Rassin D.K., Gaull G.E., Jarvenpaa A.L., and Raiha N.C. Feeding the low-birth-weight infant: II. Effects of taurine and cholesterol supplementation on amino acids and cholesterol. Pediatrics 71 (1983) 179-186
147. Rassin D.K., Raiha N.C., Minoli I., and Moro G. Taurine and cholesterol supplementation in the term infant: responses of growth and metabolism. JPEN J. Parenter. Enteral. Nutr. 14 (1990) 392-397
148. Rathmacher J.A., Nissen S., Panton L., Clark R.H., Eubanks May P., Barber A.E., D'Olimpio J., and Abumrad N.N. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J. Parenter. Enteral. Nutr. 28 (2004) 65-75
149. Rowbottom D.G., Keast D., and Morton A.R. The emerging role of glutamine as an indicator of exercise stress and overtraining. Sports Med. 21 (1996) 80-97
150. Rozen R., and Scriver C.R. Renal transport of taurine adapts to perturbed taurine homeostasis. Proc. Natl. Acad. Sci. USA 79 (1982) 2101-2105
151. Rudolph G., Kloeters-Plachky P., Sauer P., and Stiehl A. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate. Eur. J. Clin. Invest. 32 (2002) 575-580
152. Runestad, T., 2005. Four powerhouse nutrients. Functional Foods and Nutraceuticals.
153. Rytlewski K., Olszanecki R., Lauterbach R., Grzyb A., and Basta A. Effects of oral l-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. Basic Clin. Pharmacol. Toxicol. 99 (2006) 146-152
154. Schulman S.P., Becker L.C., Kass D.A., Champion H.C., Terrin M.L., Forman S., Ernst K.V., Kelemen M.D., Townsend S.N., Capriotti A., Hare J.M., and Gerstenblith G. l-Arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 295 (2006) 58-64
155. Seidl R., Peyrl A., Nicham R., and Hauser E. A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids 19 (2000) 635-642
156. Shao A., and Hathcock J.N. Risk assessment for creatine monohydrate. Regul. Toxicol. Pharmacol. 45 (2006) 242-251
157. Shao A., and Hathcock J.N. Risk assessment for the carotenoids lutein and lycopene. Regul. Toxicol. Pharmacol. 45 (2006) 289-298
158. Shin H.K., and Linkswiler H.M. Tryptophan and methionine metabolism of adult females as affected by vitamin B-6 deficiency. J. Nutr. 104 (1974) 1348-1355
159. Siani A., Pagano E., Iacone R., Iacoviello L., Scopacasa F., and Strazzullo P. Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am. J. Hypertens. 13 (2000) 547-551
160. Sirdah M.M., El-Agouza I.M., and Abu Shahla A.N. Possible ameliorative effect of taurine in the treatment of iron-deficiency anaemia in female university students of Gaza, Palestine. Eur. J. Haematol. 69 (2002) 236-242
161. Smith L.J., Lacaille F., Lepage G., Ronco N., Lamarre A., and Roy C.C. Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial. Am. J. Dis. Child 145 (1991) 1401-1404
162. Sole M.J., and Jeejeebhoy K.N. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr. Opin. Clin. Nutr. Metab. Care 3 (2000) 417-424
163. Spencer A.U., Yu S., Tracy T.F., Aouthmany M.M., Llanos A., Brown M.B., Brown M., Shulman R.J., Hirschl R.B., Derusso P.A., Cox J., Dahlgren J., Strouse P.J., Groner J.I., and Teitelbaum D.H. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. JPEN J. Parenter. Enteral. Nutr. 29 (2005) 337-343 discussion 343-334
164. Spohr C., Brons C., Winther K., Dyerberg J., and Vaag A. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus. Platelets 16 (2005) 301-305
165. Sports nutrition and weight loss markets VI. Nutr. Business J., 2006, 11 (9), 1-12.
166. Starling, S., 2004. Sports nutrition gains ground among couch potato public. Functional Foods and Nutraceuticals.
167. Stechmiller J.K., Langkamp-Henken B., Childress B., Herrlinger-Garcia K.A., Hudgens J., Tian L., Percival S.S., and Steele R. Arginine supplementation does not enhance serum nitric oxide levels in elderly nursing home residents with pressure ulcers. Biol. Res. Nurs. 6 (2005) 289-299
168. Stipanuk M.H., and Watford M. Amino acid metabolism. In: Stipanuk M.H. (Ed). Biochemical, Physiological and Molecular Aspects of Human Nutrition (2006), W.B. Saunders Company, Philadelphia, PA 360-418
169. Sturman J.A. Taurine in development. J. Nutr. 118 (1988) 1169-1176
170. Swanson B., Keithley J.K., Zeller J.M., and Sha B.E. A pilot study of the safety and efficacy of supplemental Arg to enhance immune function in persons with HIV/AIDS. Nutrition 18 (2002) 688-690
171. Tangphao O., Chalon S., Moreno Jr. H., Hoffman B.B., and Blaschke T.F. Pharmacokinetics of l-arginine during chronic administration to patients with hypercholesterolaemia. Clin. Sci. (Lond.) 96 (1999) 199-207
172. Tapiero H., Mathe G., Couvreur P., and Tew K.D. Glutamine and glutamate. Biomed. Pharmacother. 56 (2002) 446-457
173. Theilmeier G., Chan J.R., Zalpour C., Anderson B., Wang B.Y., Wolf A., Tsao P.S., and Cooke J.P. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary l-arginine. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3557-3564
174. Thistlethwaite J.R., Swanson S.C., and Scheuermann B.W. The effects of glutamine on muscle strength and body composition. (abstract). Med. Sci. Sports Exer. 37 (2005) S45
175. Thompson G.N., and Tomas F.M. Protein metabolism in cystic fibrosis: responses to malnutrition and taurine supplementation. Am. J. Clin. Nutr. 46 (1987) 606-613
176. Thompson G.N., Robb T.A., and Davidson G.P. Taurine supplementation, fat absorption, and growth in cystic fibrosis. J. Pediatr. 111 (1987) 501-506
177. Timbrell J.A., Seabra V., and Waterfield C.J. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26 (1995) 453-462
178. Trip J., Drost G., van Engelen B.G., and Faber C.G. Drug treatment for myotonia. Cochrane Database Syst. Rev. (2006) CD004762
179. Tsubuku S., Hatayama K., Mawatari K., Smriga M., and Kimura T. Thirteen-week oral toxicity study of l-glutamine in rats. Int. J. Toxicol. 23 (2004) 107-112
180. Tsubuku S., Hatayama K., Mawatari K., Smriga M., and Kimura T. Thirteen-week oral toxicity study of l-arginine in rats. Int. J. Toxicol. 23 (2004) 101-105
181. Tubman T.R., Thompson S.W., and McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst. Rev. (2005) CD001457
182. Tyson J.E., Lasky R., Flood D., Mize C., Picone T., and Paule C.L. Randomized trial of taurine supplementation for infants less than or equal to 1,300-gram birth weight: effect on auditory brainstem-evoked responses. Pediatrics 83 (1989) 406-415
183. van de Poll M.C., Dejong C.H., and Soeters P.B. Adequate range for sulfur-containing amino acids and biomarkers for their excess: lessons from enteral and parenteral nutrition. J. Nutr. 136 (2006) 1694S-1700S
184. Van Gelder N.M., Sherwin A.L., Sacks C., and Anderman F. Biochemical observations following administration of taurine to patients with epilepsy. Brain Res. 94 (1975) 297-306
185. Visek W.J. Arginine needs, physiological state and usual diets. A reevaluation. J. Nutr. 116 (1986) 36-46
186. Walker H.A., McGing E., Fisher I., Boger R.H., Bode-Boger S.M., Jackson G., Ritter J.M., and Chowienczyk P.J. Endothelium-dependent vasodilation is independent of the plasma l-arginine/ADMA ratio in men with stable angina: lack of effect of oral l-arginine on endothelial function, oxidative stress and exercise performance. J. Am. Coll. Cardiol. 38 (2001) 499-505
187. Wang W.Y., and Liaw K.Y. Effect of a taurine-supplemented diet on conjugated bile acids in biliary surgical patients. JPEN J. Parenter. Enteral. Nutr. 15 (1991) 294-297
188. Wasserhess P., Becker M., and Staab D. Effect of taurine on synthesis of neutral and acidic sterols and fat absorption in preterm and full-term infants. Am. J. Clin. Nutr. 58 (1993) 349-353
189. Watkins J.B., Jarvenpaa A.L., Szczepanik-Van Leeuwen P., Klein P.D., Rassin D.K., Gaull G., and Raiha N.C. Feeding the low-birth weight infant: V. Effects of taurine, cholesterol, and human milk on bile acid kinetics. Gastroenterology 85 (1983) 793-800
190. Williams J.Z., Abumrad N., and Barbul A. Effect of a specialized amino acid mixture on human collagen deposition. Ann. Surg. 236 (2002) 369-374 discussion 374-365
191. Wilmore D.W. Final summary: symposium on glutamine. J. Nutr. 131 (2001) 2596S-2602S
192. Wilmore D. Enteral and parenteral arginine supplementation to improve medical outcomes in hospitalized patients. J. Nutr. 134 (2004) 2863S-2867S discussion 2895S
193. Wu G., and Morris Jr. S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 Pt 1 (1998) 1-17
194. Wu G., Bazer F.W., Cudd T.A., Jobgen W.S., Kim S.W., Lassala A., Li P., Matis J.H., Meininger C.J., and Spencer T.E. Pharmacokinetics and safety of arginine supplementation in animals. J. Nutr. 137 (2007) 1673S-1680S
195. Yamashiro Y., Ohtsuka Y., Shimizu T., Nittono H., Urao M., Miyano T., Kawakami S., and Hayasawa H. Effects of ursodeoxycholic acid treatment on essential fatty acid deficiency in patients with biliary atresia. J. Pediatr. Surg. 29 (1994) 425-428
196. Yin W.H., Chen J.W., Tsai C., Chiang M.C., Young M.S., and Lin S.J. l-Arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin. Nutr. 24 (2005) 988-997
197. Zhang M., Bi L.F., Ai Y.D., Yang L.P., Wang H.B., Liu Z.Y., Sekine M., and Kagamimori S. Effects of taurine supplementation on VDT work induced visual stress. Amino Acids 26 (2004) 59-63
198. Zhang M., Bi L.F., Fang J.H., Su X.L., Da G.L., Kuwamori T., and Kagamimori S. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26 (2004) 267-271